²©¾ÅÓéÀÖÍø

Microbot, which was founded in 2010 and commenced operations in 2011, became a NASDAQ listed company on November 28, 2016. The Company specializes in transformational micro-robotic medical technologies leveraging the natural and artificial lumens within the human body. Microbot’s current platforms, ViRobâ„¢ and TipCATâ„¢, are comprised of two highly advanced micro-robotic technologies, from…More which the Company is currently developing its first two product candidates: the Self Cleaning Shuntâ„¢, or SCSâ„¢, for the treatment of hydrocephalus and Normal Pressure Hydrocephalus, or NPH; and a self-propelling, semi-disposable endoscope that is being developed initially for use in colonoscopy procedures.